Saturday 17 October 2026
Export VTR’s income statement to Excel — free account
Ventas, Inc.
VTR Real Estate Reit Healthcare Facilities
Ventas, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, up 18.5% from fiscal 2024. In the quarter to June 2026, revenue grew 21.7%, EPS fell 6.67%, free cash flow grew 13.6% and total debt fell 2.82%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for five; insiders bought in the last twelve months.
85.76
0.90
+1.06%
Follow VTR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
132.06 | 140.69 | 146.04 | 161.45 |
P/S ratio |
5.75 | 6.04 | 6.35 | 6.75 | |
P/FCF ratio |
25.84 | 27.45 | 29.01 | 31.11 | |
P/Operating CF |
84.31 | 74.66 | 98.69 | 78.07 | |
P/B ratio |
2.57 | 2.80 | 2.95 | 2.96 | |
Price to Tangible BV |
2.81 | 3.05 | 3.21 | 3.18 | |
EV/Sales |
7.97 | 8.13 | 8.36 | 8.68 | |
EV/EBITDA |
20.68 | 21.28 | 22.21 | 23.26 | |
EV/Operating CF |
28.57 | 28.81 | 29.80 | 31.04 | |
EV/FCF |
35.83 | 36.98 | 38.19 | 40.03 | |
Quick Ratio |
0.32 | 0.67 | 0.25 | 0.44 | |
Current Ratio |
0.32 | 0.67 | 0.25 | 0.44 | |
Net Debt/EBITDA |
21.42 | 20.75 | 20.68 | 19.38 | |
Debt/Assets |
46.69% | 47.16% | 45.22% | 42.78% | |
Debt/Equity |
1.01 | 1.03 | 0.95 | 0.86 | |
Asset Turnover |
0.21 | 0.22 | 0.23 | 0.23 | |
Operating CF/Net income |
5.73 | 6.72 | 7.06 | 7.89 | |
Capex/Depreciation |
(0.26) | (0.39) | (0.19) | (0.25) | |
Interest Coverage |
1.40 | 1.52 | 1.33 | 1.45 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.71% | 2.62% | 3.79% | 2.72% | |
Intangible Assets out of Total Assets |
0.04 | 0.04 | 0.04 | 0.04 | |
Share Based Compensation of Revenue |
0.40% | 0.40% | 1.50% | 0.31% | |
Graham Net Nets |
(0.44) | (0.40) | (0.36) | (0.33) | |
Graham Number |
18.02 | 18.50 | 18.68 | 19.28 | |
Earnings Yield |
0.76% | 0.71% | 0.68% | 0.62% | |
Free Cash Flow Yield |
3.87% | 3.64% | 3.45% | 3.21% | |
Revenue per Share |
3.27 | 3.44 | 3.48 | 3.54 | |
Operating CF per Share |
0.83 | 1.04 | 0.83 | 1.14 | |
Capex per Share |
(0.20) | (0.30) | (0.15) | (0.21) | |
Free Cash Flow per Share |
0.63 | 0.73 | 0.68 | 0.93 | |
Cash per Share |
0.53 | 1.73 | 0.42 | 0.46 | |
Shareholders Equity per Share |
27.24 | 27.66 | 27.68 | 30.05 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
27.24 | 27.66 | 27.68 | 30.05 | |
Free Cash Flow |
286.41 | 333.95 | 321.64 | 454.72 | |
Working Capital |
(914.59) | (453.87) | (1,016.90) | (831.72) | |
Capital Expenditures |
(92.17) | (137.71) | (72.96) | (101.83) | |
Net Current Asset Value |
(14,076.88) | (14,076.09) | (14,165.88) | (14,293.12) | |
EV/EBIT |
54.06 | 55.32 | 59.04 | 62.33 | |
Capex to Sales |
0.06 | 0.09 | 0.04 | 0.06 | |
Price to Operating Income |
39.00 | 41.07 | 44.85 | 48.43 | |
| Other line items | |||||
Average Receivables |
109.35 | 144.36 | 141.12 | 310.03 | |
Average Payables |
1,187.57 | 1,196.56 | 1,184.10 | 1,240.83 | |
Average Assets |
26,136.45 | 26,889.43 | 26,859.42 | 28,065.42 | |
Average Common Equity |
11,126.22 | 11,707.71 | 12,354.06 | 13,147.51 |
Columns are period end dates